Now a couple of years after this discovery, Pete Nelson, the R.C. Durr Foundation Chair in Alzheimer's Disease at the University of Kentucky, is working towards the second part of the dream, with the world’s first clinical trial for LATE officially underway by his colleagues at UK.
The Neighborhood Healers Project, a new pilot project led by University of Kentucky researchers, aims to reduce this equity gap by addressing the stigma and helping Black Lexingtonians access the mental health services they need.
A small black lump, about an inch or so in width, rests on the bottom of a sealed plastic container. It doesn’t look like much – in fact, it doesn’t look like anything. But this little black lump has untold potential, full of secrets for the researchers at Kentucky Research Alliance for Lung Disease (K-RALD) to discover about the pandemic that has ravaged the world for more than two years.
The University of Kentucky’s Sanders-Brown Center on Aging has been around for nearly half a century. In that time, they have built an international reputation for best-in-class research into a disease that kills more people every year than breast and prostate cancer combined – Alzheimer’s disease. There are several components to the ongoing research at Sanders-Brown, one is exploring ways to detect Alzheimer’s earlier in a person’s life.
Through reconstructing an evolutionary history, they found that genetic differences between axolotls and other salamanders in their region of Mexico were almost indistinguishable.
Recent findings in the laboratory of University of Kentucky Markey Cancer Center researcher Christine Brainson, Ph.D., could lead to promising treatments for two molecular subtypes of lung cancer.
.jpg&width=400&height=400)
The $45,000 award will support the Bitter Aloe Project, which uses machine learning models to extract data from records produced by South Africa’s Truth and Reconciliation Commission.
A team of researchers from the University of Kentucky’s Sanders-Brown Center on Aging is working to identify new proteins that are destructive to the brain. They know that about 25% of individuals, and 50% of individuals with Alzheimer disease, have the genetic mutation APOE ε4 allele — a known risk factor for the disease. Through a recent study, researchers were surprised to find that even in the brains of patients without the disease-driving mutation, ApoE proteins were enhanced in dementia. Their findings appear in The American Journal of Pathology, published by Elsevier.
The University of Kentucky has been named a 2022 Beckman Scholars Program Award winner. The award will create a new program focusing on diversity and equity in undergraduate research — Scholars United by Chemistry: Cultivating Excellence through Science Stewardship (SUCCESS). This prestigious, invite-only program for top-tier research institutions provides a 15-month mentored research experience for exceptional undergraduate students in chemistry, biological sciences and associated interdisciplinary combinations.
Aleina and Kelly Milligan are more than sisters - they are truly best friends. For Kelly, her older sister has been a lifeline during the past two years. As Kelly settled in with her sister in Columbia, Kentucky, Aleina became concerned when she noticed a change in Kelly’s seizure patterns. The sisters then made the trip to Lexington for an appointment with UK HealthCare’s Sally Mathias, M.D., assistant professor of Neurology, who specializes in epilepsy.
A new University of Kentucky Human Development Institute (HDI) program is helping to meet that need by equipping health and education professionals with the specialized skills and knowledge needed to effectively care for children with developmental disabilities.
The University of Kentucky is participating in a nationwide study that seeks to understand why some people have prolonged symptoms (long COVID) or develop new or returning symptoms after an acute bout of SARS-CoV-2 infection.
Using new methodology, University of Kentucky researchers have mapped the variations in sugar chains attached to brain proteins from deceased healthy individuals or individuals with Alzheimer’s disease. Thus far, no effective treatments for Alzheimer’s disease (AD) are available. New approaches to preventing the progression of this devastating neurological disease are desperately needed.
Researchers at the University of Kentucky’s Sanders-Brown Center on Aging recently received a five-year grant renewal of their MarkVCID program from the National Institutes of Health (NIH). The award total is more than $6 million.
Thanks to a $14 million infrastructure grant from the National Science Foundation, the University of Kentucky is poised to tell multiple heritage science stories in new, groundbreaking ways.
The University of Kentucky Office of Public Relations and Strategic Communications joined UK HealthCare hospital staff for a few days in September 2021 to document the reality of treating COVID-19 patients across the hospital system. This is chapter two in our ongoing series, “UK HealthCare: Voices from the Front Lines,” highlighting stories and perspectives from our front-line workers who have been caring for our sickest COVID-19 patients since March 2020. For more from this series, visit https://ukhealthcare.uky.edu/covid-19/voices.
A recently released paper from the Department of Physiology and Sanders-Brown Center on Aging at the University of Kentucky College of Medicine suggests that your genetics can influence your response to Alzheimer’s disease pathology.
Recent studies by the University of Kentucky's HEALing Communities Study (Helping to End Addiction Long-term) researchers show a notable rise in opioid overdose death rates among non-Hispanic Black individuals.
In the Q&A session below, Michelle Martel, a psychology professor in the College of Arts and Sciences at the University of Kentucky, shares her expertise and offers tips for helping your child cope with COVID anxiety.
University of Kentucky College of Medicine researchers were part of a new study that gives insight into how limb development evolved in vertebrates.
We recently joined hospital staff for a few days to document the reality of treating COVID-19 patients across the hospital system. This is chapter one in our ongoing series, “UK HealthCare: Voices from the Front Lines,” highlighting stories and perspectives from our front line workers who have been caring for our sickest COVID-19 patients since March 2020.
At a time when incidence of Lyme disease is rising across the U.S., a study led by University of Kentucky College of Medicine researcher Brian Stevenson, Ph.D., may provide a significant impact in the fight against the disease. A new study will build upon Stevenson's three decades of research aimed at understanding Borrelia burgdorferi, the bacteria that causes Lyme disease.
The new study, published today in Global Change Biology, reveals just how dramatically climate change has impacted aquatic ecosystems in the Sierra Nevada. Scientists can use the data to anticipate changes coming in the near future, and how those changes might influence water availability.
The University of Kentucky Center for Clinical and Translational Science has received a $23.5 million, four-year award from the National Center for Advancing Translational Sciences at the National Institutes of Health. This is the third time the CCTS has successfully competed for the prestigious Clinical and Translational Award, with continuous funding since 2011 totaling $65.4 million in research dollars.
UK HealthCare recently launched a new Pediatric Neuroendocrine Tumor Clinical and Research Program to improve treatment for children diagnosed with or at high risk for developing rare neuroendocrine tumors (NETs). This program is a joint effort between the University of Kentucky Markey Cancer Center and the Kentucky Children’s Hospital and is one of only a handful of centers specializing in this field in the world.
Research conducted at the University of Kentucky College of Medicine suggests that higher intake of specific nutrients is associated with lower brain iron concentration and better cognitive performance in older adults.
Starship Technologies rolled out its robot food delivery service yesterday on the University of Kentucky’s campus. UK’s partnership with Starship makes it one of 18 schools across the nation to use the robots.
Building on its success with previous COVID-19 vaccine studies, the University of Kentucky has been selected as a site for a trial to assess dose levels of a Johnson & Johnson booster shot.
Findings from a new University of Kentucky College of Medicine and College of Health Sciences study add to growing evidence that resistance exercise has unique benefits for fat loss. The Department of Physiology and Center for Muscle Biology study published in the FASEB Journal found that resistance-like exercise regulates fat cell metabolism at a molecular level.
A new University of Kentucky College of Medicine study published in the Journal of Biological Chemistry provides foundational information about SARS-CoV-2’s spike protein.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
